SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

TCM gets nod to finalize potential acquisition of Edayar Zinc

12 Feb 2019 Evaluate

TCM has received an approval to negotiate, finalize the terms and conditions of the proposed potential acquisition of Edayar Zinc shares within the company and sign on behalf of the Company the final ‘Term Sheet’ for the said potential acquisition and also in all necessary documents.

The Board of the company at their meeting held on February 12, 2019, authorized Joseph Varghese, Managing Director to negotiate, finalize the same.

TCM is engaged in the manufacture of Potassium Chlorate – a vital raw material for the match Industry.

TCM Share Price

47.42 -3.47 (-6.82%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3653.10
Tata Chemicals 704.05
SRF 2464.40
Pidilite Inds. 1390.15
Deepak Nitrite 1537.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×